Search
Ipsos POV: AI & Oncology
-
Would You Want to Know? The Paradox of Early Cancer Detection
Read our new viewpoint and delve into the paradox of early cancer detection: how expanding screening methods – particularly multi-cancer early detection tests – while life-saving, pose considerations such as psychological impacts, false positives, and ethical dilemmas.
-
Mid-Year Oncology Review 2025: History Informs the Future
What are the promises and limitations of different therapeutic modalities in solid tumors? As we approach the mid-year point, we reflect on the advancements in oncology in recent years.
-
Mastering complexity: The path towards a cancer-free reality
This is the third and final paper in a series which began eight years ago, focusing on unravelling – and ultimately overcoming – the sheer complexity of cancer, one of humanity’s oldest and most formidable foes.
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved – from patients and their carers to cancer treaters to the companies who manufacture and market treatments.
-
Oncology in the Time of COVID
The COVID-19 pandemic has been challenging for healthcare systems worldwide – with an already overburdened system and large population, the Indian healthcare system was no exception.
-
Conquering Complexity: The ongoing revolution in oncology biomarker testing
The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalised medicine now well-entrenched in the treatment paradigm.
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved – from patients and their carers to cancer treaters to the companies who manufacture and market treatments.